We are analyzing https://link.springer.com/article/10.1186/cvm-2-1-024.

Title:
The current status of primary prevention in coronary heart disease | Trials
Description:
During the second part of the twentieth century, research advances caused a substantial decline in the rate of coronary heart disease. The decline lasted from the mid-1960s until the early 1990s and occurred primarily in Western countries. However, an unfavourable trend in coronary heart disease related mortality has gradually developed during the 1990s, with cardiovascular diseases anticipated to remain the main cause of overall mortality for the foreseeable future. The present paper aims at analyzing the current status of the main determinants of population-wide coronary heart disease prevention.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Insurance
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

risk, google, scholar, disease, article, heart, coronary, pubmed, prevention, health, cas, chd, cardiovascular, treatment, factors, patients, cholesterol, population, bmj, european, central, primary, care, guidelines, society, british, mortality, healthcare, practice, clinical, blood, study, individuals, management, absolute, group, preventive, years, hypertension, high, smoking, table, joint, pressure, research, secondary, age, information, medicine, diseases,

Topics {✒️}

article google scholar multiple-risk-factor assessment equations angiotensin-converting enzyme inhibitors full size image acc/aha/acpasim guidelines fram-ingham equations based implementing community-wide networks deviant high-risk minority randomized controlled trial community-based prevention trials facilitate risk-factor change inappropriate long-term treatment high-density lipoprotein cholesterol high-risk preventive strategy dashed bell-shaped curve identify high-risk groups long-term adherence high-risk individuals prior chd prevention-related services extensive life-saving potential privacy choices/manage cookies low-risk group joint task force low-density lipoprotein specific community settings british diabetic association state pilot study task force proposals framingham equations computed health services research article pater general practice/family medicine british hyperlipidaemia association canadian physicians assess o'rourke ra pearson ta health service research national heart foundation hingorani ad identifying high-risk patients oslo study group high-density lipoprotein cooperative cardiovascular project risk factor categories preventive cardiology service requires fundamental reform implementing routine screening proven economically worthwhile simple computer program coronary artery disease

Questions {❓}

Grover SA, Lowensteyn I, Esrey KL, Steinert Y, Joseph L, Abrahamowicz M: How accurately do Canadian physicians assess the coronary risk in their patients?
Haq IU, Ramsey LE, Yeo WW, Jackson PR, Wallis EJ: Is the Framingham risk function valid for Northern European populations?
How well do the current cholesterol guidelines work?
Lowensteyn I, Lawrence J, Levinton C, Abrahamowicz M, Grover S: Can computerised risk profiles help patients improve their coronary risk?
This has shaped its ethics (responsibility for the sick), its research (why do individuals become sick?
Ulrich S, Hingorani AD, Martin J, Vallace P: What is the optimal age for starting lipid lowering treatment?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The current status of primary prevention in coronary heart disease
         description:During the second part of the twentieth century, research advances caused a substantial decline in the rate of coronary heart disease. The decline lasted from the mid-1960s until the early 1990s and occurred primarily in Western countries. However, an unfavourable trend in coronary heart disease related mortality has gradually developed during the 1990s, with cardiovascular diseases anticipated to remain the main cause of overall mortality for the foreseeable future. The present paper aims at analyzing the current status of the main determinants of population-wide coronary heart disease prevention.
         datePublished:2001-01-30T00:00:00Z
         dateModified:2001-01-30T00:00:00Z
         pageStart:1
         pageEnd:14
         sameAs:https://doi.org/10.1186/cvm-2-1-024
         keywords:
            cardiac
            population
            prevention
            primary
            risk
            Medicine/Public Health
            general
            Biomedicine
            Statistics for Life Sciences
            Medicine
            Health Sciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig7_HTML.jpg
         isPartOf:
            name:Current Controlled Trials in Cardiovascular Medicine
            issn:
               1468-6694
               1468-6708
            volumeNumber:2
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Cornel Pater
               affiliation:
                     name:Hertford Medical International
                     address:
                        name:Hertford Medical International, Welwyn Garden City, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The current status of primary prevention in coronary heart disease
      description:During the second part of the twentieth century, research advances caused a substantial decline in the rate of coronary heart disease. The decline lasted from the mid-1960s until the early 1990s and occurred primarily in Western countries. However, an unfavourable trend in coronary heart disease related mortality has gradually developed during the 1990s, with cardiovascular diseases anticipated to remain the main cause of overall mortality for the foreseeable future. The present paper aims at analyzing the current status of the main determinants of population-wide coronary heart disease prevention.
      datePublished:2001-01-30T00:00:00Z
      dateModified:2001-01-30T00:00:00Z
      pageStart:1
      pageEnd:14
      sameAs:https://doi.org/10.1186/cvm-2-1-024
      keywords:
         cardiac
         population
         prevention
         primary
         risk
         Medicine/Public Health
         general
         Biomedicine
         Statistics for Life Sciences
         Medicine
         Health Sciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fcvm-2-1-024/MediaObjects/13063_2000_Article_44_Fig7_HTML.jpg
      isPartOf:
         name:Current Controlled Trials in Cardiovascular Medicine
         issn:
            1468-6694
            1468-6708
         volumeNumber:2
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Cornel Pater
            affiliation:
                  name:Hertford Medical International
                  address:
                     name:Hertford Medical International, Welwyn Garden City, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Current Controlled Trials in Cardiovascular Medicine
      issn:
         1468-6694
         1468-6708
      volumeNumber:2
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hertford Medical International
      address:
         name:Hertford Medical International, Welwyn Garden City, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Cornel Pater
      affiliation:
            name:Hertford Medical International
            address:
               name:Hertford Medical International, Welwyn Garden City, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Hertford Medical International, Welwyn Garden City, UK

External Links {🔗}(248)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

6.29s.

LINK . SPRINGER . COM {}